Sumsuzzman, Dewan Md.
Ye, Yang
Wang, Zhen
Pandey, Abhishek
Langley, Joanne M.
Galvani, Alison P.
Moghadas, Seyed M.
Funding for this research was provided by:
Canadian Immunization Research Network
The Notsew Orm Sands Foundation
Natural Sciences and Engineering Research Council of Canada
Article History
Received: 22 November 2024
Accepted: 6 February 2025
First Online: 13 February 2025
Declarations
:
: Not applicable.
: Not applicable.
: JM Langley’s institution, Dalhousie University, has received funds for clinical trials conducted by the Canadian Center for Vaccinology from GSK, Janssen, Sanofi, Immunovaccine, Inventprise, Merck, Pfizer, VIDO, VBI and Entos. SM Moghadas and AP Galvani have received consultation fees from Sanofi for evaluating their vaccine products unrelated to this study. SM Moghadas had advisory roles for Janssen Canada and Sanofi and received personal fees outside the work presented here. AP Galvani has received personal fees from Sanofi outside the work presented here. Other authors declare that they have no competing interests.